Group 4 ITI Consensus Report: Risks and biologic complications associated with implant dentistry.

Lisa J A Heitz-MayfieldMerete AaboeMauricio AraujoJuan B CarriónRaffaele CavalcantiNorbert CioncaDavid CochranIvan DarbyEiji FunakoshiPetra C GierthmuehlenDena HashimLeila JahangiriYongdae KwonFrance LambertDanielle M LaytonEduardo R LorenzanaGerald McKennaAndrea MombelliFrauke MüllerMario RoccuzzoGiovanni Edoardo Salvi Martin SchimmelMurali SrinivasanCristiano TomasiAlvin Yeo

Published in: Clinical oral implants research (2019)

Diagnosis of peri-implantitis requires the presence of BOP as well as progressive bone loss. Prevalence of peri-implantitis for implants in augmented sites is low. Peri-implantitis treatment should be followed by individualized supportive care. Implant therapy for geriatric patients is not contraindicated; however, comorbidities and autonomy should be considered.

Keyphrases

bone loss
end stage renal disease
soft tissue
healthcare
risk factors
newly diagnosed
ejection fraction
chronic kidney disease
rheumatoid arthritis
multiple sclerosis
peritoneal dialysis
palliative care
prognostic factors
quality improvement
pain management
chronic pain
affordable care act
replacement therapy